Flunarizine Dihydrochloride
Form: Oral tablets
Strength: 5 mg tablets, 10 mg tablets
Reference Brands: Sibelium, Flunalix, Vertinex(EU)
Category: Antipsychotropic Drugs
Flunarizine Dihydrochloride is a calcium channel blocker widely prescribed in Europe for the prevention of migraines, treatment of vertigo, and management of certain cerebrovascular disorders. Available in oral tablet form (5 mg and 10 mg), it is marketed under brand names like Sibelium in countries including Belgium, Italy, and Spain. Though not approved in the US, Flunarizine has broad pharmaceutical demand in EU and global markets for neurology and ENT-related applications. Pharma B2B suppliers cater to healthcare providers and distributors seeking quality Flunarizine formulations. Its long half-life and proven efficacy make it a popular choice for chronic neurological care.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details Get Enquiry
Zuclopenthixol ong-acting IM Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details Get Enquiry
Zuclopenthixol Short-acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details Get Enquiry
Zuclopenthixol tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details Get Enquiry